AquaBounty Technologies (AQB) had the highest return between 2016 and 2017 by a US stock in the Biotechnology Industry, returning 48,788.9%.

ASSET	YEARS	% RETURN
AquaBounty Technologies (AQB)	2016-2017	48,788.89%
Quoin Pharmaceuticals Ltd DRC (QNRX)	2016-2017	4,437.04%
Lexaria Bioscience (LEXX)	2016-2017	924.24%
InMed Pharmaceuticals (INM)	2016-2017	749.64%
Madrigal Pharmaceuticals (MDGL)	2016-2017	694.72%
Fennec Pharmaceuticals (FENC)	2016-2017	591.03%
AnaptysBio (ANAB)	2016-2017	529.5%
Assembly Biosciences (ASMB)	2016-2017	503.33%
EXACT Sciences (EXAS)	2016-2017	485.08%
Exelixis (EXEL)	2016-2017	452.73%
Abeona Therapeutics (ABEO)	2016-2017	381.76%
Corbus Pharmaceuticals (CRBP)	2016-2017	327.71%
Theratechnologies (THTX)	2016-2017	327.61%
ProMIS Neurosciences (PMN)	2016-2017	325%
Portage Biotech (PRTG)	2016-2017	317.86%
Evotec SE ADR (EVO)	2016-2017	257.06%
argenx NV ADR (ARGX)	2016-2017	252.74%
CASI Pharmaceuticals (CASI)	2016-2017	242.11%
BeiGene (ONC)	2016-2017	237.31%
Esperion Therapeutics (ESPR)	2016-2017	201.74%
Blueprint Medicines (BPMC)	2016-2017	190.15%
Sage Therapeutic (SAGE)	2016-2017	189.27%
GlycoMimetics (GLYC)	2016-2017	189.23%
Bluebird bio (BLUE)	2016-2017	183.51%
UroGen Pharma (URGN)	2016-2017	180.2%